Purpose To evaluate the value of radiomic analysis of data from MR elastography (MRE) for diagnosing stages of fibrosis in patients with chronic hepatitis B/C (CHB/CHC). Materials and methods MRE images from 140 CHB/CHC patients with pathologically proven F0-F4 hepatic fibrosis stages were retrospectively analyzed, which is approved by our Institutional Review Board (IRB). A total of 364 radiomic features were extracted from spin-echo echo planar imaging with three-dimensional postprocessing (EPI 3D ) and gradient recalled echo with two-dimensional postprocessing (GRE 2D ) MRE data, including histogram parameters (HPs), gray level co-occurrence matrix (GLCM), and gray level run length matrix. Feature selection (significance test and correlation analysis) and classification (logistic regression models) were performed to stage ≥ F1, ≥ F2, ≥ F3 and F4, with a leave-one-out-based cross-validation method. Receiver operating characteristic analysis including areas under the curves (AUCs) was performed. Results Univariate analysis showed the best-performing features for classifying fibrosis stages were HPs (AUC range 0.798-0.929 for EPI 3D and 0.727-0.916 for GRE 2D ). In multivariate radiomic analysis, AUCs for diagnosing fibrosis of ≥ F1, ≥ F2, ≥ F3 and cirrhosis (F4) were 0.888, 0.934, 0.924 and 0.948 for EPI 3D MRE, and 0.887, 0.867, 0.892 and 0.941 for GRE 2D MRE, which were slightly higher than that of EPI and GRE stiffness for each fibrosis stage (EPI 0.816, 0.924, 0.870 and 0.918; GRE 0.882, 0.800, 0.865 and 0.911). The AUCs of the EPI 3D model were significantly higher than GRE 2D model for staging clinically significant fibrosis (0.934 vs 0.867, P = 0.030) and advanced fibrosis (0.924 vs 0.892, P = 0.029). Data conclusion Radiomic analysis of MRE facilitates fibrosis classification in CHB/CHC patients, especially for identifying intermediate fibrosis, with a higher diagnostic performance by the EPI 3D MRE.
Introduction
Chronic infections with hepatitis viruses, which include hepatitis viruses B and C, remain a major worldwide public health problem [1] . Liver fibrosis develops as a response to chronic liver injury. It is characterized by accumulations of extracellular matrix and can lead to cirrhosis, portal hypertension, liver cancer, and, ultimately, death of the patient [2] . As liver fibrosis is now proven to be a dynamic process potential with reversal, the assessments of its degree and rate of progression are of vital importance for the treatment of patients with chronic liver disease and hepatic cirrhosis [3] . Currently, liver biopsy is thought to be the reference standard for assessing liver pathology and the stage of fibrosis. However, many limitations such as invasiveness, complications of hemorrhage and infection, sampling errors, sampling variability, and problems with reproducibility have been reported [4] . Therefore, several noninvasive assessing approaches have been developed, which include laboratory tests [5] , ultrasonography (US)-based transient elastography (TE) [6] , and magnetic resonance elastography (MRE) [7] .
The latest studies have revealed that MRE has very high repeatability and validity [8, 9] for evaluating liver fibrosis. The many preliminary validation studies assessed hepatic fibrosis by the gradient-recalled echo sequence with twodimensional postprocessing (GRE 2D ) for MRE in patients with chronic hepatitis B/C (CHB/CHC) [9] [10] [11] . However, GRE 2D has a relatively high failure rate attribute to a low SNR (signal-to-noise ratio), which is due to iron overload, a common problem of advanced chronic liver diseases. A spin-echo echo planar imaging (SE EPI) sequence for MRE that produces three-dimensional (3D) maps of stiffness estimations has now been developed. It also provides increased coverage of the liver in a short acquisition time and, therefore, increased sampling efficiency. Most reports have revealed that GRE 2D and EPI 3D MRE show equivalent diagnostic performances [12] [13] [14] . In addition, another study found that the high diagnostic performance provided by EPI 3D MRE for fibrosis assessment in patients with CHB/ CHC was comparable to conventional GRE 2D MRE, which are superior to the serum biomarkers and US elastography for staging fibrosis [11] .
Radiomic analysis is a recently developed post-processing method that has the potential to facilitate retrospective evaluations that can provide additional radiological information from features on images and spatial variations of gray levels that are not discernible to the human eye. Radiomics thus uses a series of mathematical equations to identify and measure additional parameters not otherwise visualized. Several reports have used texture-based approaches such as CT or MRI [15] [16] [17] [18] , especially diffusion weighted imaging (DWI) [19] and gadoxetic acid-enhanced hepatobiliary phase MRI [20] for fibrosis assessment. To the best of our knowledge, the potential of radiomic analysis for assessing liver fibrosis from MRE data has not yet been investigated.
The aims of this study were to evaluate the diagnostic performances of MRE-based radiomic analysis for differentiating stages of fibrosis in CHB/CHC patients by comparing conventional EPI 3D and GRE 2D MRE findings, and the radiomic features extracted from EPI 3D and GRE 2D MRE images.
Materials and methods

Population
The protocols for collecting imaging data were approved by our Institutional Review Board (IRB) with all patient information removed. Since this was a retrospective study, the requirement for informed consent was waived. We initially assembled an MRE imaging dataset of 362 patients suspected of having chronic liver disease from our institution's Departments of Gastroenterology and Hepatology or Infectious Diseases between July 2015 and December 2017. Based on the inclusion and exclusion criteria ( Fig. 1 ), a total of 207 patients who had underwent both liver biopsy and MRE were selected. Of these patients, 31 cases were excluded because of failed MRE (GRE failure: n = 24; EPI failure: n = 7), 36 cases excluded because of unreliable/ unfeasible histopathological results (n = 36), and the final cohort were 140 cases. Patient characteristics and epidemiological data were obtained at the time of liver biopsy. The flow diagram of patient selection is illustrated in Fig. 1 .
Assessment of pathologic specimens
In accordance with the routine clinical evaluation protocol, all patients had undergone ultrasound-guided percutaneous liver biopsy. Histological preparations from liver biopsy specimens were retrospectively reviewed by two pathologists with more than 15 years of experience in assessing liver fibrosis. The pathologists were blinded to patient identities and MRE data. The METAVIR scoring system was used for a semiquantitative fibrosis stage [21] : F0, absence of fibrosis; F1, portal fibrosis without septa formation; F2, enlargement of portal tract and significant fibrosis with few septae; F3, severe fibrosis with numerous septa but without cirrhosis; and F4, cirrhosis. Any discrepancy between the two pathologists in the staging of a patient was discussed until consensus was achieved.
MR acquisitions
A Signa Excite HD 3T scanner (Signa HDX 3.0T system; GE Healthcare, Milwaukee, WI, USA) with an 8-element body coil was used to obtain all MRE data. An active acoustic generator placed outside the MRI examination room generated 60-Hz pneumatic vibrations [10, 11, 22] that were delivered by means of a plastic tube to a passive driver placed in right upper abdomen of the patient inside the scanning room. The Mayo Clinic (Rochester, MN, USA) had developed the generator, passive driver, and sequences, which were provided to our institution along with a service agreement. Table 1 shows the MR protocol details. The central slice of eight slices of EPI MRE was fixed on the same level as the one slice of GRE MRE.
MR image processing
Software provided by the Mayo Clinic was used to perform processing on the scanner during each MRE acquisition.
For both GRE and EPI, stiffness maps were created (elastogram image) [23] . All the images (32 EPI sections and 4 GRE sections) were processed by a radiologist with 5-year MRE experience who was, blinded to the patients' identities and medical histories. The radiologist first reviewed the confidence map and wave images, and with the help of visual anatomical landmarks, selected an individual central section on each sequence that matched the magnitudes as closely as possible of the other individual sections on the other sequences. The selected elastograms and magnitudes were imported into Analysis Kit (AK) software (GE Healthcare, Guangzhou Province, China). The regions of interest (ROIs) with a mean area > 1500 mm 2 per slice were drawn and analysed on elastogram images manually on an image of the right liver lobe with reference to conventional MR images, anatomic adjacent landmarks were used to adjust the ROIs and exclude large vessels, bile ducts, liver fissures, the portal area, areas with motion artifacts, and the liver edge [22, 24, 25] . Figure 2 illustrates the analysis pipeline.
Feature extraction
AK software performed the calculations for 364 radiomic features of each ROI, including histogram parameters (HPs), which were regarded as first-order features, gray-level cooccurrence matrix (GLCM) and gray-level run length matrix (GLRLM). For the HPs, the 40 features were computed to evaluate the distribution of voxel intensities of the image. For the GLCM and GLRLM, the 144 and 180 radiomic features were extracted ( Table 2 ). The GLCM matrix represents the joint probability pixel sets with certain gray-level values, whose g(i, j) element counts pixels with gray-level i which are adjacent to pixels with gray-level j. Eight kinds of GLCM features were extracted and calculated for the given rotation angels of 0°, 45°, 90° and 135°, within three distances (termed as offset) of 1, 4 and 7. The averages and standard deviations (SDs) of the parameters for each offset were also computed. As a direction θ given, the GLRLM matrix p(i, j, θ) counts the numbers of runs with pixels of gray-level i as well as run length j. Ten kinds of GLRLM features (with the averages and SDs) for the same four directions in the three offsets were calculated. Feature details are listed in Supplementary Materials. All of the radiomic features in Table 2 were computed and collected, with the algorithms implemented in Analysis Kit (AK) software (GE Healthcare, Guangzhou Province, China).
Statistical analyses
The conventional liver stiffness and the radiomic features from the EPI 3D and GRE 2D MRE data were expressed as mean ± standard deviation (SD) to assess the mild fibrosis, significant fibrosis, advanced fibrosis and cirrhosis by comparing the groups of F0 vs F1-4 (≥ F1), F0-1 vs F2-4 (≥ F2), F0-2 vs F3-4 (≥ F3) and F0-3 vs F4 (= F4). The diagnostic performances of conventional measurements of stiffness values and radiomic feature univariables were evaluated by receiver operating characteristic (ROC) curve analysis and areas under the curves (AUCs) with a leaveone-out cross-validation (LOOCV) method. One observed value was picked up for validation, and the other cases were used as the training set for prediction by ROC analysis in each LOOCV loop. For multivariate analysis, we first standardized all the values of the radiomic features using the z-score method by means of the formula: Y = X− , where X is the initial feature value, μ the mean, and σ the standard deviation of the features. Second, the differences between radiomic features in each group were assessed by significance test and the features without statistical significance were excluded as follows: The Shapiro-Wilk and Bartlett's test were used to assess normality and homogeneity of variances, respectively. Statistical differences were evaluated by Student's t test for the data accorded with normal distribution and homogeneity of variance, and otherwise the nonparametric Kruskal-Wallis test was used. Third, redundancy reduction was performed by Spearman's correlation test and the Spearman rank correlation coefficient [Spearman's rho (ρ)] was calculated to assess the similarity between each two feature variables. With respect to features with high correlation (the absolute value of Spearman's ρ ≥ 0.8), the variable with the lower AUC value was removed. Finally, the selected features were retained and used as input variables for analysis by a subsequent multiple logistic regression model that employed a LOOCV method to avoid overfitting of classifiers, of which diagnostic performances were evaluated by ROC curve analysis and AUCs repeated for all the LOOCV folds as stated above.
The diagnostic characteristics of the models and conventional liver stiffness using each imaging method, including accuracy, sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were determined For datasets with different fibrosis stages (F0-F4), we extracted radiomic features from both three-dimensional spin-echo echo planar imaging (EPI 3D ) and twodimensional gradient recalled echo (GRE 2D ) magnetic resonance elastography (MRE) images by drawing regions of interest (ROIs). After feature selection by the assessment of robustness and removal of redundancy, multivariate analysis was performed on the data from the features for a cutoff point that maximized the value of the Youden index. AUCs were compared using the method proposed by DeLong et al. [26] . A P value < 0.05 was considered to be statistically significant. All statistical analyses were performed by R software, ver. 3.4.3 (Foundation for Statistical Computing, Vienna, Austria).
Results
Patient characteristics
The EPI 3D and GRE 2D MRE data from a total of 140 (74 (52.8%) male and 66 (47.2%) female) patients with CHB/ CHC were eligible for the evaluation of liver stiffness ( Fig. 1 shows the selection protocol). The mean age of the patients was 51.3 ± 10.3 years (range 23-64 years). The time interval between MRE and liver biopsy in all the cases were 1 week or less. The baseline characteristics of patients are summarized in Table 3 .
Univariate Analysis of MRE Image Features for Staging Fibrosis
The top AUCs of representative features from different radiomic categories analyzed in the MRE images were evaluated using univariate regression classifiers (Tables 4, 5). In general, the features of HPs showed excellent diagnostic performances, with AUC values ranging from 0.798-0.929 for EPI 3D and 0.727-0.916 for GRE 2D MRE images, without significantly different comparisons between each individual histogram parameter and stiffness value. The GLCM and GLRLM results indicated lower discriminative power, with AUC values ranging from 0.554-0.714 and 0.568-0.584 for EPI 3D , and 0.581-0.649 and 0.559-0.645 for GRE 2D , respectively, compared to the stiffness values (P < 0.001). Particularly, the best-performing features for detecting fibrosis were percentiles, which yielded AUC values of 0.817 (≥ F1), 0.929 (≥ F2), 0.873 (≥ F3) and 0.921 (= F4) for EPI 3D , and 0.889 (≥ F1), 0.806 (≥ F2), 0.870 (≥ F3) and 0.916 (= F4) for GRE 2D , without significantly different comparisons against EPI and GRE stiffness values. Figure 3 shows EPI and GRE MRE images with ROIs from two representative patients with F0 and F2 fibrosis. Figure 4 initially shows approximately excellent diagnostic performances for staging fibrosis by MRE conventional stiffness and radiomic feature models. By means of a LOOCV, the values for AUCs and the diagnostic characteristics of conventional measurements of liver stiffness and of MRE features derived from of radiomic analysis of EPI and GRE data are shown in Table 6 . EPI MRE stiffness values showed slightly larger AUCs than GRE for differentiating stages of fibrosis, as follows: ≥ F1 (0.888 vs 0.887, P = 0.184), ≥ F2 (0.934 vs 0.867, P = 0.158), ≥ F3 (0.924 vs 0.892, P = 0.141), and F4 (0.948 vs 0.941, P = 0.181), although the differences were not significant for any fibrosis stage. Multiple logistic regression analysis of the MRE variables identified by univariate analysis showed that generally, the AUC values of features from radiomic analysis of EPI and GRE MRE were higher than the values from conventional stiffness measurements from EPI and GRE MRE for the detection of mild fibrosis (P EPI = 0.091, P GRE = 0.145), significant fibrosis (P EPI = 0.066, P GRE = 0.030), advanced fibrosis (P EPI = 0.123, P GRE = 0.022) and cirrhosis (P EPI = 0.106, P GRE = 0.113). The AUC value from radiomic analysis of an EPI feature was significantly higher than the AUC value from radiomic analysis of a GRE feature for significant fibrosis (0.934 vs 0.867, respectively; P = 0.030) and advanced fibrosis (0.924 vs 0.892, respectively; P = 0.029). The AUC values for conventional EPI stiffness measurements were slightly higher than those derived from radiomic analysis of GRE features for the detection of mild, significant, and advanced fibrosis stages, but lower for cirrhosis, and without statistical significance at any stage of fibrosis. showed higher NPVs of 0.938, 0.958, 0.982 and sensitivities of 0.918, 0.911, 0.933 than radiomic analysis of GRE 2D MRE data and conventional stiffness measurements.
Multivariate analysis of MRE image features for staging fibrosis
Discussion
The results of our study indicated that the textural features of HPs were the main parameters that could differentiate between fibrosis stages, and that GLCM and GLRLM features showed somewhat lower diagnostic power. Radiomic analysis of MRE data yielded parameters that showed good diagnostic characteristics for distinguishing different stages of liver fibrosis, especially the significant and advanced stages, which performed significantly between MRE models and conventional stiffness. With respect to radiomic analysis of MRE modalities that provided parameters that could be used to differentiate between significant and advanced fibrosis, EPI 3D MRE provided higher diagnostic performance values (AUC, sensitivity, specificity, PPV and NPV) than GRE 2D MRE. The field of quantitative evaluation of medical images, also known as radiomics, has been shown to be useful for predicting patient survival [27] , providing a differential diagnosis of tumors [28] , and staging histologic subtypes of tumors [29] . In the liver, quantitative evaluations of parenchymal texture [17, 18] have been used to stage fibrosis. This study, along with several other studies, has considered texture to be a spatial arrangement of predefined voxel numbers, which thus enables the discovery of complicated characteristics of the image. Textural parameters were measured by calculations mathematically derived from how the voxels were arranged, regularly or irregularly, thus assessing the degree of liver stiffness. Radiomic analysis of the deep convolutional neural network (DCNN) of gadoxetic acid-enhanced hepatobiliary phase MR imaging showed that liver fibrosis stages F4, F3, and F2 were diagnosed with AUCs of 0.84, 0.84, and 0.85, respectively. Other studies have reported that quantitative radiomic analyses of T2-weighted images [15] and extracellular gadolinium-enhanced images [30] for the diagnosis of advance fibrosis resulted in AUCs of 0.81 and 0.80, respectively. As mentioned previously, differences in the microscopic features of liver fibrosis and cirrhosis should lead to differences in T1-weighted signals due to differences in contrast enhancement, T2-weighted signals due to differences in the content of water, and DWI due to diffusivity differences. Therefore, radiomic analysis of different MRI sequences may differently perform. In this study, the textural parameters of HPs provided intermediate or high correlation with mean stiffness values (because of differences in stiffness), which have been widely proven by MRE reports to show high diagnostic performance for the classification of fibrosis [31, 32] . Compared with the previously cited study reports, our study demonstrated the best diagnostic performance, and these textural features can be considered to be optimal parameters superior to conventional stiffness values. Furthermore, the GLCM and GLRLM parameters represented the heterogeneity of images, which suggests the development of liver fibrosis and cirrhosis to be heterogeneous processes characterized by spatially inhomogeneous histopathological evolvements, as previous pathological and MRE studies have reported [22, 33] . If the heterogeneity of the development of hepatic fibrosis is confirmed, this characteristic indicates that the accuracy of a diagnostic biopsy is susceptible to sampling variability. For example, although a fibrotic liver might be staged F2 by biopsy, it might contain a combination of a relatively large area of F2 with a smaller area of F3, which cannot be defined and distinguished from a similarly large F3/small F4 distribution biopsy-proven to be stage F3 by mean stiffness. However, such spatial heterogeneity results in differences in textural features to some extent for staging F2 or F3. With a more comprehensive characterization of liver stiffness provided from EPI 3D MRE data, radiomic feature model should provide a diagnostic method that will not be affected by the sampling variability problem of biopsy procedures. Although most established reports have proven that EPI 3D might demonstrate a slightly higher diagnostic performance than GRE 2D MRE, the diagnostic performance of the former is not conclusively superior to that of the latter in regard to staging fibrosis. In our study, we found that radiomic analysis of EPI 3D MRE images provided more significant information from the GLCM and GLRLM categories of clustershades, inertias, and short run emphasis for differentiating fibrosis, especially significant and advanced fibrosis. The results suggest that the increased detecting capacity of EPI 3D MRE imaging for hepatic stiffness features might be attributed to its high image quality and low SNR. Nevertheless, most of the published studies on MRE for liver fibrosis detection have used GRE MRE [9, 34, 35] . In this study, EPI 3D MRE images showed better diagnostic performance than GRE 2D MRE for both conventional MRE measurements and combinations with radiomic analysis that provided textural features. The improved diagnostic performance is a result of the radiomic features extracted from the MRE images, which are related to the heterogeneity and quality of the image. EPI 3D MRE has 3 advantages over GRE 2D MRE, namely, less susceptibility effects, less sensitive to T2* decay (associated with iron overload), and a shorter scanning time and larger confidence map. In addition, GRE 2D MRE images often have artifacts around the edges of the liver because of susceptibility effects, which worsen at higher field strengths and are avoided by SE imaging. EPI with 3D vector MRE processing may also reduce the artifacts due to wave scattering or diffraction effects and propagation arising in GRE 2D MRE analysis [36, 37] . Iron deposition, usually found in patients with advanced hepatic fibrosis and cirrhosis, is considered to be the most common cause of MRE failure [34] . The sensitivity to T2* decay of SE EPI sequence is lower than the GRE sequence and, therefore, less susceptible to the effects of iron deposition or field inhomogeneity. A strong correlation was found between liver T2* values and each image quality score and ROI size [38] . Finally, the shorter acquisition time of EPI 3D MRE reduces artifacts due to respiratory motion and allows shorter duration of breath-holds, which is especially helpful for patients with diminished breath-hold capabilities. EPI 3D MRE can acquire multiple slice images during a single breath-hold, which leads to increased liver coverage. EPI 3D MRE has lower stiffness measurements because of through-plane propagation waves and different inversion algorithms [10] .
In clinical studies, MRE has been found to provide better diagnostic performance for fibrosis than serum biomarkers and US-based elastography [39] . Although both conventional MRE stiffness measurements and MRE-based models provide similar diagnostic performances for the staging of mild fibrosis and cirrhosis, the radiomic analysis of EPI 3D and GRE 2D MRE data, which yields additional features, is superior for further analysis of significant and advanced fibrosis. In addition, for patients with hepatic iron overload, small hepatic volume, or inability to maintain breath-holds, which are challenging for GRE 2D , we suggest the use of EPI 3D MRE instead.
Our study has several limitations. First, its retrospective design was limiting. Second, our study enrolled a fair number of patients, but the distributions of patients with different stages of fibrosis were not equivalent. There were, relatively fewer patients with F2 (n = 16) and F3 (n = 15) fibrosis. For cross-validation, we used the leave-one-out method on the same patient dataset; Third, the ROIs and measurements of stiffness were performed by a single primary radiologist; therefore, the reproducibility and repeatability of measurements were not studied. Fourth, radiomics features were only extracted from MRE images and T1WI-and T2WI-based textures were not analyzed. Future work will propose and compare a variety of models and algorithms for staging fibrosis from MRE images by machine learning, and we will also carry out MRE studies of liver fibrosis and cirrhosis of different etiologies.
In conclusion, for the assessment of hepatic fibrosis in CHB/CHC patients, MRE-based radiomic analysis provides a higher diagnostic performance comparable to conventional MRE measurements. Radiomic analysis of data from EPI 3D MRE provides a diagnostic performance superior to GRE 2D , especially for staging significant and advanced fibrosis. The combination of MRE with MREbased radiomic analysis could offer an alternative to invasive liver biopsy potentially in clinical practice.
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